These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 5053842

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The para-aminosalicylic acid (PAS) level of the venous blood in patients after the administration of various PAS preparations for pulmonary tuberculosis].
    Kreukniet J, Tasman A, Bangma PJ.
    Ned Tijdschr Geneeskd; 1965 Sep 18; 109(38):1760-1. PubMed ID: 5317952
    [No Abstract] [Full Text] [Related]

  • 3. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A, Borgå O, Sjöqvist F.
    Scand J Respir Dis; 1970 Sep 18; 51(1):61-9. PubMed ID: 5456864
    [No Abstract] [Full Text] [Related]

  • 4. [Early results of a modified treatment of 100 cases of newly detected tuberculosis with standard drugs with the substitution of PAS for ethionamide].
    Piekarniak K, Danilczuk R, Martyniak K, Wyczółkowski M.
    Gruzlica; 1973 Aug 18; 41(8):837-43. PubMed ID: 4755391
    [No Abstract] [Full Text] [Related]

  • 5. [Studies on the metabolism of para-aminosalicylic acid in the body. VI. Absorption, tolerance and therapeutic effect of Napashin in double gastro-enteric coating].
    Nikodemowicz E, Owsiñski M, Kamiñska M, Ostrowska A, Rapf T.
    Gruzlica; 1971 Nov 18; 39(11):1113-21. PubMed ID: 5137653
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Early results of intermittent and continuous modified treatment with standard drugs and limited dosage of PAS in previously untreated pulmonary tuberculosis. Preliminary report].
    Stopczyk J, Niemirowska H, Pecyna-Sielewicz J, Janowiec M.
    Gruzlica; 1970 Nov 18; 38(7):705-18. PubMed ID: 5453680
    [No Abstract] [Full Text] [Related]

  • 8. [Isoniazide-tiocarlide combination or DAT in the treatment of pulmonary tuberculosis. Comparison with isoniazide-PAS combination and especially BPAS].
    Meyer A, Nadjar-Fossé G.
    Rev Tuberc Pneumol (Paris); 1968 Nov 18; 32(3):371-80. PubMed ID: 5693998
    [No Abstract] [Full Text] [Related]

  • 9. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E, Abadi O, Pretet S.
    Rev Tuberc Pneumol (Paris); 1969 Nov 18; 33(7):967-74. PubMed ID: 5402999
    [No Abstract] [Full Text] [Related]

  • 10. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G, Petitjean R, Schranz J, Scherrer B.
    Rev Tuberc Pneumol (Paris); 1970 Nov 18; 34(3):439-53. PubMed ID: 5515514
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical study of various compounds of PAS].
    Potworowska M, Wareska W, Lachowicz E, Pecyna-Sielewicz J, Ambroziak-Miller M.
    Gruzlica; 1969 Jul 18; 37(7):673-80. PubMed ID: 4900504
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tolerance to ethionamid and PAS in original treatment of tuberculous patients.
    Verbist L, Prignot J, Cosemans J, Gyselen A.
    Scand J Respir Dis; 1966 Jul 18; 47(4):225-35. PubMed ID: 5182290
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical tolerance of rifampycin administered alone or in combination with other antitubercular drugs].
    Carratù L, Sonaglioni F, Natali P.
    Arch Tisiol Mal Appar Respir; 1968 May 18; 23(5):399-410. PubMed ID: 5306592
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative studies of tolerance of pasomycin, streptomycin and pas in ambulatory patients].
    Rudoĭ NM, Fisher IuIa, Bril LN.
    Antibiotiki; 1972 Jan 18; 17(1):76-9. PubMed ID: 5019440
    [No Abstract] [Full Text] [Related]

  • 20. [Concentration in the blood and excretion of para-aminosalicylic acid and its metabolites after intake of BEPAS preparation].
    Savula MM.
    Probl Tuberk; 1973 Jan 18; 51(10):44-7. PubMed ID: 4784037
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.